Cargando...
Obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons
The pandemic of COVID-19 is changing the usual clinical practice. Most of the drugs used for the etiotropic and pathogenetic therapy of COVID-19 do not have a sufficient evidence base, approaches to therapy of liver, gastrointestinal tract and other body systems damage in the structure of COVID-19 a...
Gardado en:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Remedium Group LLC
2021-05-01
|
| Series: | Медицинский совет |
| Assuntos: | |
| Acceso en liña: | https://www.med-sovet.pro/jour/article/view/6166 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|